share_log

SVB Leerink Maintains Market Perform on Landos Biopharma, Lowers Price Target to $3

Benzinga Real-time News ·  Aug 12, 2022 06:50

SVB Leerink analyst Thomas Smith maintains Landos Biopharma (NASDAQ:LABP) with a Market Perform and lowers the price target from $16 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment